Navigation Links
New Research from Best Practices, LLC can Improve Formulary Access and Product Placement for Biopharma Companies: Managed Markets Market Research
Date:2/18/2010

CHAPEL HILL, N.C., Feb. 18 /PRNewswire/ -- Companies invest hundreds of millions – and occasionally billions – of dollars overall in developing new drugs and face countless hurdles in bringing these new products to market.  To make good on these vast investments, successful companies must maximize product uptake across all customer groups: not only among patients and physicians, but also among government and private payers to win formulary access and improve product placement.  

In fact, these payer groups, who represent millions of individual consumers, compose biopharma's largest revenue base and earning a favorable formulary tier position with a single large carrier can open the door to hundreds of millions in potential revenue.

Companies face two main problems in gaining traction with large payer groups. First, since the market for most therapeutic areas and medical conditions is already crowded with similar treatments, companies must to be able to articulate a clear medical or economic advantage for their products.  Second, companies often struggle to gain access to key decision makers within the Managed Markets organization.

By anticipating payer attitudes and behavior early on in the product lifecycle, a high-functioning Managed Markets market research group can prove invaluable in setting clinical and commercial strategy.  In addition, savvy Managed Markets market research groups also provide vital insight and value by delivering reliable and actionable knowledge of the ever evolving Managed Markets landscape.  

A new benchmarking study from Best Practices, LLC, Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight, explores the proven strategies that best-in-class companies have mastered.  With a benchmark class that features Abbott, GSK, Johnson & Johnson and Novo Nordisk among others, this research examines dozens of Managed Markets market research activities all of which help companies meet new regulatory and legislative challenges and build fruitful relationships with key decision makers at large payer organizations.

To download a complimentary study excerpt, or to view a sample of key topics and study findings, go to: http://www3.best-in-class.com/rr989.htm .

To learn more about Best Practices' other timely research visit: http://www3.best-in-class.com or contact Benjamin Gregory at 919-767-9160 or bgregory@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 

SOURCE Best Practices, LLC

RELATED LINKS
http://www3.best-in-class.com/

'/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
2. IPA Helps Researchers Utilize and Share Current Disease Knowledge Through New Dynamic Reporting Capability
3. Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine
4. US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
5. Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research
6. Northern Light Surpasses $2 Billion Worth of Research Content Integrated Into SinglePoint Strategic Research Portals
7. New Research Gives Insight to the Frequency of Doctor Shopping Occurring Within Prescription Monitoring Programs
8. Medical Research Council Technologys Centre for Therapeutics Discovery Opens its First Call For Targets in an Effort to Develop Drugs in Areas of Serious Unmet Need
9. Americas Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti; More Help Coming
10. ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report
11. Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
Breaking Medicine Technology:
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
Breaking Medicine News(10 mins):